Reata Pharmaceuticals (RETA)
NASDAQ:RETA
Holding RETA?
Track your performance easily

Reata Pharmaceuticals (RETA) Stock Investors

453 Followers
Based on 703,211 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RETA
On average, investors allocate 5.01% of their portfolios to RETA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 703,211 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RETA

1.3%
Last 7
Days
6.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RETA, out of 703,211 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RETA Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.09%
$99.68
Opened
0.00%
$89.70
Based on the activity of 12,880 investors who made their portfolios public
The table shows changes in RETA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RETA Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.10%
-0.41%
+1.09%
39.31B
Healthcare
Micron
5.62%
-0.06%
-1.50%
74.51B
Technology
Coherus Biosciences
2.48%
-1.04%
+811.90%
413.18M
Healthcare
Roku
5.14%
-0.62%
-2.42%
8.76B
Technology
Trade Desk
5.04%
-0.74%
-2.86%
34.87B
Technology
Marvell
4.82%
-0.41%
+1.02%
46.70B
Technology
Merck & Company
4.61%
-0.09%
-1.79%
261.24B
Healthcare
Salesforce
4.85%
+0.19%
-0.13%
197.30B
Technology
Block
4.16%
-0.25%
+0.21%
24.32B
Technology
Uber Technologies
5.71%
-0.18%
+0.04%
93.98B
Technology
Based on the activity of 703,211 active portfolios
Open your Smart Portfolio

RETA Investor Analysis

RETA investors under 35

Under 35

1.3%
Last 30 days
Holdings Change
17.6%
of RETA holders
are under 35
Average Segment Performance
Average P/E Ratio20.30
Beta8.53
Dividend Yield13.56%
RETA investors between 35–55

Between 35–55

1.6%
Last 30 days
Holdings Change
50.0%
of RETA holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.05
Beta12.75
Dividend Yield23.61%
RETA investors over 55

Over 55

11.6%
Last 30 days
Holdings Change
32.4%
of RETA holders
are over 55
Average Segment Performance
Average P/E Ratio16.59
Beta5.76
Dividend Yield11.70%
Overview of age group and performance of RETA stock investors
See who invests in RETA according to age group and performance.

FAQ

How many retail Investors hold RETA?
<0.1% of TipRanks' retail investors hold RETA in their portfolios.
    What is RETA Investor Sentiment?
    RETA’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RETA in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of RETA in the last 7 days.
        What percentage of retail investors changed their holding of RETA in the last 30 days?
        ▼ 6.7% of TipRanks' retail investors changed their holding of RETA in the last 30 days.
          What is the average age of retail investors who hold RETA?
          The average age of RETA Holders is between 35–55.
            What other stocks have RETA investors also bought?
            RETA Investors also bought MRNA, MU, CHRS, ROKU, TTD, MRVL, MRK, CRM, SQ, UBER.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              LCTXLineage Therap
              CHRSCoherus Biosciences
              COOCooper Co
              DVADaVita
              DXCMDexcom
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis